在结直肠癌的背景下,非编码RNA和HIF-1alpha之间的相互作用
Lianfeng Gong1, Haixia Zhang1, Ying Liu1
1School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou 434023, China.
Biomolecules
|April 30, 2025
概括
非编码RNAs (ncRNAs) 和低氧诱导因子-1α (HIF-1α) 形成调节网络,推动结直肠癌 (CRC) 的进展. 了解这种交叉通话为新型诊断生物标志物和向治疗提供了潜力.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 缺氧诱导因子-1α (HIF-1α) 是结肠直肠癌 (CRC) 进展的关键调节剂,促进血管生成,转移和治疗耐药性.
- 非编码RNAs (ncRNAs),包括microRNAs (miRNAs),长非编码RNAs (lncRNAs) 和圆形RNAs (circRNAs),越来越多地被认为是它们在癌症中的作用.
- ncRNA和HIF-1α之间的双向调节网络正在成为编排CRC病变和缺氧瘤微环境的关键参与者.
研究的目的:
- 综合最近关于ncRNAs和HIF-1α在CRC中的相互作用机制的研究.
- 探索ncRNA/HIF-1α交叉的临床潜力,作为诊断生物标志物和治疗点.
- 突出基于ncRNA的CRC疗法的有希望的未来研究方向.
主要方法:
- 文献综述侧重于ncRNAs和HIF-1α在结直肠癌中的相互作用.
- 在PubMed,Web of Science和EMBASE等数据库中进行系统搜索.
- 包括在特定日期范围内发表的研究 (例如2000-2025年),以确保相关性和及时性.
主要成果:
- ncRNAs通过与HIF-1α的复杂交叉调节CRC进展,影响血管生成,转移和治疗抵抗.
- 特定的lncRNAs和miRNAs已经在非侵入性液体活检中证明了CRC检测的潜力.
- ncRNA/HIF-1α相互作用有助于低氧CRC瘤微环境的攻击性.
结论:
- 在结直肠癌中,ncRNA/HIF-1α轴代表了一个重要的调节网络.
- 准ncRNA-HIF-1α相互作用对开发CRC新型诊断工具和治疗策略具有前景.
- 对ncRNA功能及其临床应用的进一步研究是有必要的,以推进CRC治疗.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
MicroRNAs
2.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
Types of RNA
5.5K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.5K


